全文获取类型
收费全文 | 6470篇 |
免费 | 565篇 |
国内免费 | 473篇 |
专业分类
耳鼻咽喉 | 39篇 |
儿科学 | 70篇 |
妇产科学 | 77篇 |
基础医学 | 684篇 |
口腔科学 | 147篇 |
临床医学 | 759篇 |
内科学 | 965篇 |
皮肤病学 | 131篇 |
神经病学 | 303篇 |
特种医学 | 307篇 |
外国民族医学 | 1篇 |
外科学 | 586篇 |
综合类 | 1143篇 |
预防医学 | 597篇 |
眼科学 | 195篇 |
药学 | 677篇 |
5篇 | |
中国医学 | 353篇 |
肿瘤学 | 469篇 |
出版年
2023年 | 77篇 |
2022年 | 91篇 |
2021年 | 247篇 |
2020年 | 181篇 |
2019年 | 223篇 |
2018年 | 223篇 |
2017年 | 181篇 |
2016年 | 179篇 |
2015年 | 239篇 |
2014年 | 341篇 |
2013年 | 309篇 |
2012年 | 422篇 |
2011年 | 435篇 |
2010年 | 304篇 |
2009年 | 246篇 |
2008年 | 319篇 |
2007年 | 452篇 |
2006年 | 355篇 |
2005年 | 283篇 |
2004年 | 409篇 |
2003年 | 474篇 |
2002年 | 419篇 |
2001年 | 337篇 |
2000年 | 208篇 |
1999年 | 108篇 |
1998年 | 58篇 |
1997年 | 70篇 |
1996年 | 55篇 |
1995年 | 44篇 |
1994年 | 23篇 |
1993年 | 29篇 |
1992年 | 16篇 |
1991年 | 29篇 |
1990年 | 22篇 |
1989年 | 18篇 |
1988年 | 4篇 |
1987年 | 12篇 |
1986年 | 6篇 |
1985年 | 11篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1977年 | 5篇 |
1976年 | 2篇 |
1968年 | 4篇 |
1967年 | 6篇 |
1959年 | 2篇 |
排序方式: 共有7508条查询结果,搜索用时 15 毫秒
1.
Yuka Ikeda Kurumi Taniguchi Haruka Sawamura Ai Tsuji Satoru Matsuda 《World journal of gastroenterology : WJG》2022,28(31):4471-4474
Irritable bowel syndrome (IBS) is an important health care concern. Alterations in the microbiota of the gut-brain axis may be linked to the pathophysiology of IBS. Some dietary intake could contribute to produce various metabolites including D-amino acids by the fermentation by the gut microbiota. D-amino acids are the enantiomeric counterparts of L-amino acids, in general, which could play key roles in cellular physiological processes against various oxidative stresses. Therefore, the presence of D-amino acids has been shown to be linked to the protection of several organs in the body. In particular, the gut microbiota could play significant roles in the stability of emotion via the action of D-amino acids. Here, we would like to shed light on the roles of D-amino acids, which could be used for the treatment of IBS. 相似文献
2.
Norio Itokawa Masanori Atsukawa Akihito Tsubota Noritomo Shimada Hidenori Toyoda Koichi Takaguchi Atsushi Hiraoka Tomonori Senoh Mai Koeda Yuji Yoshida Tomomi Okubo Taeang Arai Korenobu Hayama Ai Nakagawa-Iwashita Chisa Kondo Katsuhiko Iwakiri 《Internal medicine (Tokyo, Japan)》2021,60(4):507
Objective Pegylated-interferon monotherapy is the standard treatment for patients with chronic hepatitis B; however, the factors associated with its therapeutic effects remain unclear. Methods Patients with chronic hepatitis B were treated with pegylated interferon α-2a for 48 weeks. We evaluated the kinetics of hepatitis B surface antigen (HBsAg) during treatment and follow-up periods and the factors associated with an HBsAg response (defined as a change in HBsAg of ≥-1 log IU/mL from baseline). Results The study population comprised 50 patients. The median baseline levels of hepatitis B virus DNA and HBsAg were 5.00 and 3.40 log IU/mL. The median values of HBsAg reduction from baseline were -0.44 (n=48), -0.41 (n=40), and -0.68 (n=11) log IU/mL at the end of treatment and at 48 and 144 weeks post-treatment, respectively. The rates of HBsAg response were 24.0% and 22.5% at the end of treatment and at 48 weeks post-treatment, respectively. A multivariate analysis identified HBsAg <3.00 log IU/mL as an independent baseline factor contributing to the HBsAg response at the end of treatment and 48 weeks post-treatment (p=1.07×10-2 and 4.42×10-2, respectively). There were significant differences in the reduction of the HBsAg levels at 12 weeks of treatment and in the incidence of serum ALT increase during treatment between patients with and without an HBsAg response. Conclusion These findings suggest that the baseline HBsAg level, HBsAg kinetics at 12 weeks of treatment, and ALT increase during treatment are important factors contributing to the HBsAg response in pegylated interferon α-2a monotherapy for patients with chronic hepatitis B. 相似文献
3.
Shi Qiu Linghui Deng Xinyang Liao Ling Nie Fang Qi Kun Jin Xiang Tu Xiaonan Zheng Jiakun Li Liangren Liu Zhenhua Liu Yige Bao Jianzhong Ai Tianhai Lin Lu Yang Qiang Wei 《Cancer science》2019,110(7):2110-2118
The tumor microenvironment is associated with various tumor progressions, including cancer metastasis, immunosuppression, and tumor sustained growth. Tumor‐associated macrophages (TAMs) are considered an indispensable component of the tumor microenvironment, participating in the progression of tumor microenvironment remodeling and creating various compounds to regulate tumor activities. This study aims to observe enriched TAMs in tumor tissues during bladder cancer development, which markedly facilitated the proliferation of bladder cancer cells and promoted tumor growth in vivo. We determined that TAMs regulate tumor sustained growth by secreting type I collagen, which can activate the prosurvival integrin α2β1/PI3K/AKT signaling pathway. Furthermore, traditional chemotherapeutic drugs combined with integrin α2β1 inhibitor showed intensive anticancer effects, revealing an innovative approach in clinical bladder cancer treatment. 相似文献
4.
Yuh‐Shyan Tsai Yeong‐Chin Jou Hsin‐Tzu Tsai Ai‐Li Shiau Chao‐Liang Wu Tzong‐Shin Tzai 《Cancer science》2019,110(4):1208-1219
Prothymosin‐α (PTMA) is a small, acidic protein that is usually transported into the nucleus and involves many cellular and immunological functions. Previous studies demonstrated that aberrant location of PTMA expression exists in human bladder cancer, but the role of PTMA protein expression remains elusive. In this study, we created ectopic nuclear or cytoplasmic PTMA expression in human bladder cancer cells by infecting lentiviruses carrying wild type or deleted nuclear localization signal of the PTMA gene. The in vivo tumorigenesis assay showed PTMA protein with deleted nuclear localization signal promotes J82 xenograft tumor growth in mice and shortens their survival more so than the wild type. Chromatin immunoprecipitation showed that wild‐type PTMA protein binds to the PTEN promoter and enhances phosphatase and tensin homolog (PTEN) expression. Through immunoblot proteomics and in vivo ubiquitination studies, PTMA protein can bind with tripartite motif‐containing protein 21 (TRIM21) and block its ubiquitination. Also, TRIM21 can downregulate both forms of PTMA protein. In human bladder tumors, loss of nuclear PTMA expression was an unfavorable prognostic indicator for shorter disease‐free survival (hazard ratio, 1.54; P = 0.009). Our data support that nuclear PTMA protein serves as a tumor suppressor in bladder cancer through upregulating PTEN and orchestrating TRIM21 for the regulation of Nrf2 signaling. 相似文献
5.
6.
7.
8.
9.
10.